YOUQING SHEN化学工程与生物工程学院化学工程与技术· 用于癌症治疗的高效纳米药物的设计与合成· 高效非病毒基因输送载体的设计· 用于癌症早期诊断的高灵敏性磁共振成像（MRI）造影剂的设计· 功能性树枝状大分子的高效合成个人简介:申有青，教育部长江学者特聘教授、浙江大学求是特聘教授。91、95年分别获浙江大学学士和理学博士学位，获首届《全国优博论文奖》；02年获加拿大McMaster University工学博士学位。02年起任美国怀俄明大学（University of Wyoming）助理教授，07年被破格晋升为tenure的副教授，08年回国任浙江大学全职求是学者教授和生物纳米工程中心主任，获08年的杰青资助，2009年入选“浙江省海外高层次人才引进计划”（百人计划）2014年起任国家重大科学研究计划项目首席科学家。申有青教授从事功能高分子合成及其作为新型智能药用辅料材料用于肿瘤靶向纳米制剂的研究。主持了国家杰出青年基金、973前期研究专项、国家基金委重大项目课题和子课题、国家重大科学研究计划纳米专项项目（任首席）等。迄今在重要的学术期刊上共发表SCI论文190篇，SCI H-因子50；其中近五年SCI他引2623次，单篇最高150次，2015年和2016年连续入选中国高被引学者材料科学榜。研究方向:一、用于癌症治疗的纳米药物载体的设计与合成       研究方向包括新型纳米载体的设计与合成、靶向纳米药物的制备、纳米药物的体外毒性及机理、纳米药物在细胞内的传输过程、纳米药物的体内（裸鼠）的靶向性能和药效（如抗癌性能）、临床实验等。 目前的工作之一是研制能够靶向肿瘤细胞器的纳米药物载体，从而将药物直接输送到它们的作用靶点，使药物同时避开各种抗药机制 提高药物的药效。本纳米药物的优点是药物直接到达其作用靶点、克服多种抗药机制。图 1.癌细胞的抗药机制图 2. 激光共聚焦观察纳米药物载体在肿瘤细胞核中的定位图 3. 三维构建二、高效非病毒基因输送载体的设计       通过基因疗法 (Gene Therapy) 即将目标基因导入靶细胞的核内以表达所需蛋白从而达到治疗之目的，可以改变癌细胞来降低其包括细胞核内抗药机制在内的各种抗药性。基因疗法的瓶颈是基因的靶向传送。病毒类载体介导的基因传送具有高的转染率和良好的靶向性，但多个临床实验发现病毒类载体容易引起人体复杂的免疫反应而导致病人死亡并会致癌。阳离子型聚合物也可用做基因传送的载体。它具有毒性低，不会引起机体的过度免疫反应的优点，但它的缺点是基因表达效率低。有鉴于此，我们目前的研究工作是研制能够模拟病毒体的聚合物/DNA的自组装体作为DNA的高效输送载体。图 4. pH-调节逐步自组装的PCL/PDEA/PEG梳状高分子形成模拟病毒纳米颗粒用于基因输送三、用于癌症早期诊断的高灵敏性磁共振成像（MRI）造影剂的设计和开发       肿瘤早期发现是治愈癌症的关键。例如，早期肾癌的五年存活率可达到99％，而二期以上的病人五年存活率只有16％。但是，许多肿瘤在早期并没有症状，因而很难被发现，而被发现时已到晚期或已发生转移。磁共振成像(MRI)在临床中被越来越广泛地用于癌症的诊断，但它的灵敏性还不够高，误诊率比较高且造成许多不必要的组织活切诊断。MRI的灵敏性取决于造影剂。常用MRI造影剂是稀土金属离子Gd3＋的小分子或大分子络合物。研究发现，将Gd3＋络合到大分子载体上，能显著提高MRI的灵敏性，但它们的灵敏性还有待进一步提高。       我们致力于研制种癌组织靶向和肿瘤特异性激活型造影剂载体，该载体同时还能显著提高核磁共振中肿瘤部位的对比度。已与浙大附属邵逸夫医院放射科的胡红杰主任医师开展合作，以期获得能应用于临床的高灵敏性MRI造影剂，用于肿瘤的早期诊断。图 5. 合作单位邵逸夫医院放射科提供的小鼠头部核磁共振图四、树枝状大分子的高效合成       树枝状大分子因其精确的三维纳米分子结构，被广泛作为纳米技术平台应用于医药领域，如作为药物和基因运输载体。然而，传统的树枝状大分子合成方法复杂，需要保护/去保护及繁琐的纯化过程限制了树枝状大分子的大规模应用。我们发明了一种聚酯树枝状大分子的高效合成方法，即采用在化学反应性上不对称的单体和功能基团之间的点击化学反应，通过“不对称单体对”间的简单交替“粘贴”的方法合成聚酯树枝状大分子。该方法合成步骤简单，目标产物为唯一的大分子，因而纯化过程极为简便，可广泛用于生物可降解聚酯的大规模生产应用，如作为药物传输载体。图 6. 不对称单体的点击反应快速制备树枝状大分子图 7.反应溶液的MALDI-TOF MS(a)与树枝状大分子的GPC谱(b)五、前药为多功能纳米载体       大多数抗癌药物在水中的溶解性差，且有些药物分子（如喜树碱的内酯环）在血液中不稳定，极大限制了抗癌药物的临床应用。药物输送技术是解决上述问题的有效途径之一。此外，通过药物载体可延长药物的半衰期，且能通过肿瘤组织的EPR效应提高药物在肿瘤部位的聚集，提高药物的靶向性并降低其毒副作用。然而，目前药物输送体系亟需解决的问题是载药能力太低。如在纳米颗粒载体或脂质体内，载药量一般不超过10%，且载药体系不稳定，在血液中存在突释现象，导致药物的生物利用度低且可能导致系统生物毒性。低载药量也造成治疗时需使用大量的医用载体辅料，对机体产生毒副作用。我们利用药物分子本身的疏水性或亲水性，以药物分子作为疏水或亲水部分，通过与亲水基团或疏水基团的共价结合来制备自乳化药物前药。该前药溶于缓冲液中即形成纳米囊泡或纳米颗粒，且既是原药的载体，又可携带其他药物，并具有肿瘤靶向功能，因此成为多功能的纳米抗癌药物。图 8. 喜树碱前药形成纳米纳米囊泡装载阿霉素（上图），并利用激光共聚焦显微镜确定其细胞内定位（下图）SKOV-3 ovarian cancer cells were incubated with PEG-DiCPT/DOX′HCl at a DOX dose of 1μg/ml for 5h at 37°C.Upper panel: Observation of the lysosomal localization: from the DOX channel (a) LysoTracker green (DND-26to label lysosomes) channel(b)，and the overlap of the(a) and (b) images(c). Lower panel: Observation of the nuclear localization: from the DOX channel(d) the nuclear dye DRAQ5 channel(e) and the overlap of the(d) and(e) images(f) (larger view images are shown in Figure S5 in Supporting Information).教学与课程:生物纳米技术        研究生课程生物化工前沿        研究生课程化工技术进展        研究生课程研究与成果:Intracellularly Disintegratable Polysulfoniums for Efficient Gene Delivery2716:-Synthesis and properties of zwitterionic dendrimer as drug and imaging probe carrier213:E144-E145用单一单体高效合成聚羟基丙烯亚胺树状高分子02:-Elastin-like polypeptide fusion for precision design of protein-polymer conjugates with improved pharmacology5810:767-768Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery289:1743-1752Synthesis of an Esterase-Sensitive Degradable Polyester as Facile Drug Carrier for Cancer Therapy544:507-515Special issue of ChinaNanomedicine 2015122:353-353Folic acid targeting charge-reversal conjugate of norcantharidin for cancer chemotherapy122:470-470Cascade-released nanoassembly for cancer drug delivery122:471-472Polymeric prodrug micelles with tunable size probing the balance between tumor accumulation and penetration for cancer drug delivery122:476-477Fabrication of dendrimer-releasing lipidic nanoassembly for cancer drug delivery46:958-969A novel brush-shaped copolymer for drug delivery213:E120-E120Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization2914:-Paclitaxel improved gene transfection efficiency through cell synchronization in SW480 cells213:E83-E83Preparation and Imaging Study of Tumor-targeting MRI Contrast Agent Based on Fe3O4 Nanoparticles4412:1771-1773Multilayered Nanoparticles for Controlled Release of Paclitaxel Formed by Near-Critical Micellization of Triblock Copolymers4511:4809-4817Dendrimers with the protocatechuic acid building block for anticancer drug delivery431:5236-5245YOUQING SHEN.Enhancing MRI of liver metastases with a zwitterionized biodegradable dendritic contrast agent58:1588-1595Produg nanoparticles: Structural parameters affecting pharmacokinetics243:-YOUQING SHEN.Esterase-Activated Charge-Reversal Polymer for Fibroblast-Exempt Cancer Gene Therapy:-Jumping the nuclear envelop barrier: Improving polyplex-mediated gene transfection efficiency by a selective CDK1 inhibitor RO-3306234:90-97Redox-Activatable ATP-Depleting Micelles with Dual Modulation Characteristics for Multidrug-Resistant Cancer Therapy68:-A linear polyethylenimine (LPEI) drug conjugate with reversible charge to overcome multidrug resistance in cancer cells76:150-158Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A5351-2:164-171Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy1237:5108-5119Facile Synthesis of Poly(hydroxypropylene imine) Dendrimer from a Single Monomer2:359-366In vitro inhibition of cancer stem cells by biguanidine-based macromolecular drug213:E79-E79Amphiphilic drugs as surfactants to fabricate excipient-free stable nanodispersions of hydrophobic drugs for cancer chemotherapy220:175-179A theoretical hypothesis on co-precipitation of hydrophobic antitumor drug and amphiphilic block copolymers213:E98-E99.Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo519:2517-2527.Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibroblast induced drug resistance144:105-118.A Tumor-Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in Cancers2938:-Zwitterionic poly(lysine methacrylate) brush as an effective carrier for drug delivery213:E27-E28Isothermal Carbon Dioxide Sorption in Poly(ionic liquid)s4820:9113-9118Facile synthesis of polyester dendrimers from sequential click coupling of asymmetrical monomers13141:14795-14803Charge-Reversal Drug Conjugate for Targeted Cancer Cell Nuclear Drug Delivery1922:3580-3589Charge-reversal drug conjugate for targeted cancer cell nuclear drug delivery1922:3580-3589Prodrugs Forming High Drug Loading Multifunctional Nanocapsules for Intracellular Cancer Drug Delivery13212:4259-4265Isothermal carbon dioxide sorption in poly(ionic liquid)s4820:9113-9118Facile Synthesis of Polyester Dendrimers from Sequential Click Coupling of Asymmetrical Monomers13141:14795-14803Charge-Reversal Drug Conjugate for Targeted Cancer Cell Nuclear Drug Delivery1922:3580-3589Curcumin polymers as anticancer conjugates3127:7139-7149Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery13212:4259-4265Curcumin polymers as anticancer conjugates3127:7139-7149Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers359:1128-1143Pentadentate Copper Halide Complexes Have Higher Catalytic Activity in Atom Transfer Radical Polymerization of Methyl Acrylate Than Hexadentate Complexes4213:4531-4538Degradable Poly(beta-amino ester) nanoparticles for cancer cytoplasmic drug delivery52:192-201Tertiary Amine - Enhanced Activity of ATRP Catalysts CuBr/TPMA and CuBr/Me6TREN2922:1834-1838Poly(ionic liquid)s: Novel materials for CO2 absorption.229:379-PMSE-CO2 absorption of polymers of ammonium-based ionic liquid monomers229:31-PMSE-Carbon dioxide absorption of poly(ionic liquid)s with different ionic structures230:578-PMSE-CO2 permeability diffusivity and solubility in polyethylene glycol-grafted polyionic membranes and their CO2 selectivity relative to methane and nitrogen2811-2:130-138Carbon dioxide absorption of poly(ionic liquid)s with different ionic structures230:U3777-U3777Poly(ionic liquid)s: Novel materials for CO2 absorption.229:U1162-U1162申有青.CO2 absorption of polymers of ammonium-based ionic liquid monomers229:U1107-U1107Degradable dual pH- and temperature-responsive photoluminescent dendrimers1719:5319-5326Platinum (IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug delivery3234:9136-9143Linear polyethyleneimine-based charge-reversal nanoparticles for nuclear-targeted drug delivery2147:19114-19123Multilayered nanoparticles for controlled release of paclitaxel formed by near-critical micellization of triblock copolymers4511:4809-4817beta-Cyclodextrin-based biodegradable dendrimers for drug delivery152:E89-E90Synthesis and characterization of a novel dendritic magnetic resonance imaging contrast agent152:E256-E257Amphiphilic block copolymer of prodrugs by atom transfer radical polymerization and their self-assembly242:-Self-assembly of dendrimer/lipid for drug delivery242:-Degradable water soluble hyperbranched polymers for drug delivery152:E76-E78Platinum (IV)-coordinate polymers for cancer drug delivery152:E108-E109Nuclear drug delivery for cancer chemotherapy155:227-236Linear polyethyleneimine-based charge-reversal nanoparticles for nuclear-targeted drug delivery2147:19114-19123Nuclear drug delivery for cancer chemotherapy1552:227-236Platinum (IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug delivery3234:9136-9143Degradable Dual pH- and Temperature-Responsive Photoluminescent Dendrimers1719:5318-5325Challenges in design of translational nanocarriers1642:156-169Facile synthesis and in vivo evaluation of biodegradable dendritic MRI contrast agents2229:14369-14377Conjugate of Pt(IV)-Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy910:2793-2800Acid-active cell-penetrating peptides for in vivo tumor-targeted drug delivery1352:933-940Facile synthesis of polyester dendrimers as drug delivery carriers461:37-42Macromolecular MRI contrast agents: Structures properties and applications383-4:462-502Targeted acid-labile conjugates of norcantharidin for cancer chemotherapy2231:15804-15811Targeted acid-labile conjugates of norcantharidin for cancer chemotherapy2231:15804-15811Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging1693:239-245Macromolecular MRI contrast agents: Structures properties and applications383-4:462-502Facile synthesis and in vivo evaluation of biodegradable dendritic MRI contrast agents2229:14369-14377Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery3422:5722-5735Challenges in design of translational nanocarriers1642:156-169Facile Synthesis of Polyester Dendrimers as Drug Delivery Carriers461:37-42Acid-Active Cell-Penetrating Peptides for in Vivo Tumor-Targeted Drug Delivery1352:933-940Bioreducible poly(amido amine)s with different branching degrees as gene delivery vectors1103:990-998A TRIBUTE TO A LIVING LEGEND84:IX-IXpH Responsive Behavior of Fe3O4@PDEA-PEGMA Core-Shell Hybrid Magnetic Nanoparticles6310:487-492Translational nanomedicine from self-assembling prodrugs246:-Jellyfish-Shaped Amphiphilic Dendrimers: Synthesis and Formation of Extremely Uniform Aggregates473:916-921Translational nanomedicine from self-assembling prodrugs246:-Tumor Redox Heterogeneity-Responsive Prodrug Nanocapsules for Cancer Chemotherapy2527:3670-3676Self-assembling doxorubicin prodrug forming nanoparticles for cancer chemotherapy: synthesis and anticancer study in vitro and in vivo13:284-292Synthesis and Properties of a Biodegradable Dendritic Magnetic Resonance Imaging Contrast Agent321:91-96Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging (vol 169 pg 239 2013)1721:258-258Self-assembling doxorubicin prodrug forming nanoparticles for cancer chemotherapy: Synthesis and anticancer study in vitro and in vivo13:284-292Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: In vitro and in vivo studies1662:147-158In Vivo and in Situ Tracking Cancer Chemotherapy by Highly Photostable NIR Fluorescent Theranostic Prodrug1369:3579-3588Functional and biodegradable dendritic macromolecules with controlled architectures as nontoxic and efficient nanoscale gene vectors324:818-830Viral Mimicking Ternary Polyplexes: A Reduction-Controlled Hierarchical Unpacking Vector for Gene Delivery2610:1534-1540Facile synthesis of size-tunable stable nanoparticles via click reaction for cancer drug delivery574:633-644Parallel synthesis of polymers from epoxy-amine reaction for gene delivery1721:E118-E118Biodegradable charge-reversal PEI derivative for gene transfection1721:E109-E110Jellyfish-shaped amphiphilic dendrimers: Synthesis and formation of extremely uniform aggregates473:916-921Hepatic-Targeted Gene Delivery Using Cationic Mannan Vehicle1110:3322-3329Nanocarrier improves the bioavailability stability and antitumor activity of camptothecin4771-2:536-545Molecularly precise dendrimer-drug conjugates with tunable drug release for cancer therapy5341:10949-10955Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice209:260-271Integration of Nanoassembly Functions for an Effective Delivery Cascade for Cancer Drugs2645:7615-7621Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy2527:3670-3676Molecularly Precise Dendrimer-Drug Conjugates with Tunable Drug Release for Cancer Therapy5341:10949-10955Molecularly Precise Dendrimer-Drug Conjugates with Tunable Drug Release for Cancer Therapy5341:10949-10955A multifunctional PEG-PLL drug conjugate forming redox-responsive nanoparticles for intracellular drug delivery338:7594-7603A linear polyethylenimine (LPEI) drug conjugate with reversible charge to overcome multidrug resistance in cancer cells76:150-158Amphiphilic drugs as surfactants to fabricate excipient-free stable nanodispersions of hydrophobic drugs for cancer chemotherapy220:175-179A multifunctional PEG-PLL drug conjugate forming redox-responsive nanoparticles for intracellular drug delivery338:7594-7603Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice209:260-271Improving the gene transfection efficiency of polyethylenimine (PEI) based polyplex nanoparticles by cell cycle regulation122:473-473Transferrin-modified liposome promotes alpha-mangostin to penetrate the blood-brain barrier122:421-430主要学术兼职:美国化学工程师学会(AIChE)会员美国化学学会(ACS)会员美国国家科学基金评审委员(20032005200620072008)、美国化学会Petroleum Fund基金、加拿大国家科学与工程研究委员会(NSERC Canada) 基金评审员怀俄明大学软物质实验室主任，2005/1-2008/62011 Int. Symposium on Functional Polymers and Nanomedicine (ISFPN) 执行主席。国际期刊International Journal of Pharmaceutics和Nanomedicine编委Chinese Journal of Chemical Engineering编委浙江省特聘专家国家自然科学基金委员会第十三、十四届化学科学部专家评审组成员中国生物材料学会理事中国抗癌协会纳米肿瘤学专业委员会委员招生信息:本课题组的研究集中在以新功能材料的设计与合成为基础的生物纳米材料/工程的研究。主要研究工作内容为新功能生物纳米材料的设计与合成、智能纳米材料与药物及生物大分子的组装及智能纳米载体材料在生物、医学上的应用， 特别是智能纳米药物载体用于癌症的治疗和早期诊断。该研究是化学、材料、高分子、化学工程、生物工程、分子/细胞生物学、药学、肿瘤医学、临床医学等学科的交叉。不同专业背景的同学在应用自己的专业知识的同时，将与其它专业背景的同学及临床医师合作进行科研工作并完成课题。因此，上述专业的同学都可以找到自己感兴趣的课题，并得到多学科背景的综合训练，大大拓宽知识面。欢迎各专业有识之士加入本课题组，更多信息可移步课题组网站（http://che.zju.edu.cn/others/bionano）